Involvement of tumor necrosis factor-α receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation

被引:13
|
作者
Tashiro, H
Itamoto, T
Ohdan, H
Arihiro, K
Tateaki, Y
Nakahara, H
Ochi, M
Hino, H
Mizunuma, K
Hara, H
Tokita, D
Onoe, T
Ishiyama, K
Mitsuta, H
Sugino, K
Asahara, T
机构
[1] Hiroshima Univ, Fac Med, Dept Surg 2, Minami Ku, Hiroshima 7348551, Japan
[2] Hiroshima Univ Hosp, Dept Pathol, Hiroshima, Japan
[3] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Dev Biol Lab, Hiroshima, Japan
关键词
ischemia; reperfusion injury; apoptosis; necrosis; liver allograft; death receptor;
D O I
10.1007/s00147-004-0762-z
中图分类号
R61 [外科手术学];
学科分类号
摘要
The pathway leading to cell death in clinical liver transplantation is not known. Eight liver transplant recipients and eight donors were enrolled in this study. Postoperative serum levels of alanine transferase had significantly increased in the recipients compared with those in the donors. Mild centri-lobular necrosis was observed in only liver tissues taken from the recipients. Tumor necrosis factor (TNF)-R1 and death receptor 5 expression levels had increased in liver tissues taken from the recipients. There were no changes in the levels of Fas/Fas ligand expression in liver tissues from either the donors or recipients. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression was down-regulated in donor liver after hepatectomy and liver allograft after implantation. The results suggest that, although ischemic liver injury was not serious, due to the short ischemia time, TNF and TRAIL signals are associated with liver ischemic injury in live-donor liver transplantation but Fas signal is not.
引用
收藏
页码:626 / 633
页数:8
相关论文
共 50 条
  • [31] Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor
    Wu, GS
    Burns, TF
    Zhan, Y
    Alnemri, ES
    El-Deiry, WS
    CANCER RESEARCH, 1999, 59 (12) : 2770 - 2775
  • [32] Expression of tumor necrosis factor-related apoptosis-inducing ligand receptors 1 and 2 in melanoma
    McCarthy, Mary M.
    Di Vito, Kyle A.
    Sznol, Mario
    Kovacs, Daniela
    Halaban, Ruth
    Berger, Aaron J.
    Flaherty, Keith T.
    Camp, Robert L.
    Lazova, Rossitza
    Rimm, David L.
    Kluger, Harriet M.
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3856 - 3863
  • [33] Targeting the tumor necrosis factor-related apoptosis-inducing ligand path in neuroblastoma
    Yang, XH
    Thiele, CJ
    CANCER LETTERS, 2003, 197 (1-2) : 137 - 143
  • [34] Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils
    Kamohara, H
    Matsuyama, W
    Shimozato, O
    Abe, K
    Galligan, C
    Hashimoto, SI
    Matsushima, K
    Yoshimura, T
    IMMUNOLOGY, 2004, 111 (02) : 186 - 194
  • [35] Expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in human colorectal adenocarcinomas.
    Younes, M
    Carlson, N
    All, N
    Younes, A
    GASTROENTEROLOGY, 2000, 118 (04) : A1419 - A1419
  • [36] Mechanisms of sensitivity and resistance of melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
    Kurbanov, B. M.
    Fecker, L. F.
    Sterry, W.
    Eberle, J.
    EXPERIMENTAL DERMATOLOGY, 2007, 16 (03) : 263 - 263
  • [37] Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
    Lin, Zhihua
    Lei, Huanzong
    Cao, Peng
    PROTEIN EXPRESSION AND PURIFICATION, 2007, 51 (02) : 276 - 282
  • [38] Dammarenolic acid sensitizes cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
    Kroeger, A.
    Proksch, P.
    Kampkoetter, A.
    Waetjen, W.
    Kahl, R.
    Chovolou, Y.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 72 - 72
  • [39] The Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Lung Cancer Still Following the Right TRAIL?
    McGrath, Emmet E.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : 983 - 987
  • [40] Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene
    Kagawa, S
    He, C
    Gu, J
    Koch, P
    Rha, SJ
    Roth, JA
    Curley, SA
    Stephens, LC
    Fang, BL
    CANCER RESEARCH, 2001, 61 (08) : 3330 - 3338